Press release on the suspension of trading in ASIT Biotech

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 14/09/2021 at 11:00 CET until the publication of a press release.

Source: FSMA

Related Posts